Sionna Therapeutics · 2 weeks ago
Vice President Corporate Communications
Greater Boston
Full-time
Hybrid
Director/Executive
$280K/yr - $325K/yr
15+ years expSionna Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel medicines for cystic fibrosis. The Vice President, Corporate Communications will lead and execute the company’s communications strategy, managing both internal and external communications to align with Sionna’s corporate vision and objectives.
BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics
Hiring Manager
Roxanne McGrath
Responsibilities
Develop and execute a comprehensive corporate communications strategy and narrative that reflects Sionna’s vision, clinical progress, corporate strategy, and culture
Lead media relations strategy and build strong relationships with trade, business, and scientific journalists
Partner with investor relations to lead material development for corporate announcements including R&D milestones, regulatory updates, and corporate developments
Create and implement internal communications strategies that engage employees, reinforce culture, and support organizational change
Partner with HR to drive employee communications strategy and engagement
Define and strengthen the company’s brand, ensuring consistent messaging across digital platforms, conferences, events, and publications
Lead development of executive visibility programs including thought leadership, keynote speaking, and media commentary
Oversee digital presence and strategy including website and social media
Manage external agencies and vendors to extend communications reach and capabilities
Collaborate cross-functionally to ensure consistent messaging to key stakeholders including employees, investors, media, scientific and patient communities
Qualification
Required
15+ years of progressive experience in corporate communications in biotechnology or the broader life sciences industry
Proven experience leading both internal and external communications, including digital and social strategy and media relations
Track record of success partnering closely with senior leadership and investor relations in a public company environment
Experience supporting communications for clinical data readouts, scientific conferences, and regulatory milestones
Ability to translate complex science and data into compelling and accessible content for diverse audiences
Exceptional written and verbal communication skills
Strategic thinker with a proactive mindset and the ability to operate both at a high level and be hands-on
Experience working in an agile, collaborative, and science-driven environment
Prior experience managing vendors and agencies; budget management experience required
Demonstrated experience coaching senior leaders on communications best practices
Bachelor's degree required
Preferred
Advanced degree in communications, journalism, or life sciences a plus
Company
Sionna Therapeutics
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).
11-50 employees
Funding
Current Stage
Public CompanyTotal Funding
$292MKey Investors
Enavate SciencesOrbiMed
2025-02-07IPO
2024-03-06Series C· $182M
2022-04-19Series B· $110M
Leadership Team
Michael Cloonan
President and Chief Executive Officer
Greg Hurlbut
Co-founder and SVP Head of Research
Recent News
2026-01-06
MarketScreener
2025-12-22
MarketScreener
2025-11-28
Company data provided by crunchbase